Insight journal - Company

Bristol-Myers Squibb: Partnering activity 2005-2013

Posted on 17 March 2013

Tags: , ,

Bristol-Myers Squibb announced over 160 partnering / licensing deals since 2005, with over 30 deals in 2012 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in oncology, cardiovascular, infectives, metabolic and psychiatric diseases.

Abstracted from: Partnering Deals and Alliances with Bristol-Myers Squibb

The number of partnering, collaborative R&D and licensing deals announced remained steadily year on year with an increase recently to a peak of 34 deals announced in 2012.

The following figure shows the level of BMS partnering deal announcements since 2005.

Figure 1: Bristol-Myers Squibb partnering deals 2005-2013

BMS deals by year 2005-2013

Source: Current Agreements, 2013

Analysis of the partnering deals shows a strong emphasis on partnerships in oncology, cardiovascular, infectives, metabolic and psychiatric diseases. This reflects the focus areas of BMS.

The following table provides an overview of the partnering deals announced by Bristol-Myers Squibb based on therapy area disclosed. Our report provides more detailed insight into the precise therapeutic target of each deal. See: Partnering Deals and Alliances with Bristol-Myers Squibb

Figure 2: Bristol-Myers Squibb partnering deals by therapy area 2005-2013

BMS deals by therapy

Source: Current Agreements, 2013

Further analysis of these deals shows that BMS has a preference for licensing deals, similar to many other top pharmaceutical or big pharma companies. Such partnering deals provide the right for BMS to exploit the licensors technology in return for payment of upfront, development and sales, and royalty payments. In addition, BMS has a tendency for collaborative R&D, research and development agreements. These are a consequence of BMS’s emphasis on the discovery and development of novel medicinal products.

The following table provides an overview of the partnering deals announced by BMS based on deal type disclosed.

Figure 3: Bristol-Myers Squibb partnering deals by deal type 2005-2013

BMS deals by type

Source: Current Agreements, 2013

When looking at stage of development at partnering deal signing, the most popular stage at signing is discovery stage with 34 deal announcements, closely followed preclinical and then early stage clinical stage deals. BMS, in common with many other top pharmaceutical companies, participates in marketed stage deals for the optimal commercialization of their product portfolio.

The following table provides an overview of the partnering deals announced by BMS based on stage of development at signature.

Figure 4: Bristol-Myers Squibb partnering by stage of development 2005-2013

BMS deals by stage

Source: Current Agreements, 2013

Bristol-Myers Squibb has signed over 160 partnering and licensing deals since 2005. The following provides a summary of the top deals by headline value.

Figure 5: Top Bristol-Myers Squibb partnering deals by headline value 2005-2013

BMS deals by value

Source: Current Agreements, 2013

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Bristol-Myers Squibb

Bristol-Myers Squibb partnering at Current Agreements

View all partnering deals for Bristol-Myers Squibb: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Deals and Alliances with Bristol-Myers Squibb

More

Summary profile data for BMS

Partnering interests for BMS

M&A activity for BMS

 

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Bristol-Myers Squibb

Report: Partnering Deals and Alliances with Big Pharma

 

Available resources for deal coverage for Bristol-Myers Squibb

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Bristol-MyersSquibb company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

 

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply